Summit Therapeutics Future Growth
Future criteria checks 0/6
Summit Therapeutics is forecast to grow revenue at 85.4% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 0% |
Revenue growth rate | 85.4% |
Future return on equity | -29.4% |
Analyst coverage | Low |
Last updated | 18 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 48 | N/A | N/A | -286 | 4 |
12/31/2025 | N/A | N/A | N/A | -165 | 4 |
12/31/2024 | N/A | N/A | N/A | -148 | 4 |
9/30/2024 | N/A | -197 | -128 | -113 | N/A |
6/30/2024 | N/A | -162 | -98 | -97 | N/A |
3/31/2024 | N/A | -116 | -94 | -94 | N/A |
12/31/2023 | N/A | -615 | -552 | -77 | N/A |
9/30/2023 | N/A | -598 | -527 | -52 | N/A |
6/30/2023 | 0 | -598 | -521 | -46 | N/A |
3/31/2023 | 0 | -600 | -511 | -36 | N/A |
12/31/2022 | 1 | -79 | -42 | -42 | N/A |
9/30/2022 | 1 | -87 | -57 | -56 | N/A |
6/30/2022 | 2 | -85 | -72 | -71 | N/A |
3/31/2022 | 2 | -93 | -72 | -71 | N/A |
12/31/2021 | 2 | -89 | -73 | -73 | N/A |
9/30/2021 | 2 | -75 | -72 | -71 | N/A |
6/30/2021 | 1 | -73 | -65 | -64 | N/A |
3/31/2021 | 1 | -64 | -64 | -64 | N/A |
12/31/2020 | 1 | -53 | -49 | -48 | N/A |
9/30/2020 | 1 | -51 | -49 | -49 | N/A |
6/30/2020 | 1 | -40 | -38 | -37 | N/A |
3/31/2020 | -5 | -31 | -18 | -18 | N/A |
12/31/2019 | 1 | -32 | -23 | -23 | N/A |
10/31/2019 | 26 | -28 | -24 | -23 | N/A |
7/31/2019 | 24 | -27 | -20 | -19 | N/A |
4/30/2019 | 72 | 12 | -24 | -24 | N/A |
1/31/2019 | 57 | 11 | -35 | -35 | N/A |
10/31/2018 | 70 | 2 | -36 | -36 | N/A |
7/31/2018 | 72 | 11 | N/A | -45 | N/A |
4/30/2018 | 27 | -29 | N/A | -19 | N/A |
1/31/2018 | 20 | -29 | N/A | -21 | N/A |
10/31/2017 | 15 | -18 | N/A | -20 | N/A |
7/31/2017 | 12 | -23 | N/A | 31 | N/A |
4/30/2017 | 5 | -27 | N/A | 14 | N/A |
1/31/2017 | 3 | -27 | N/A | 15 | N/A |
10/31/2016 | 1 | -29 | N/A | 15 | N/A |
7/31/2016 | 1 | -33 | N/A | -26 | N/A |
4/30/2016 | 1 | -32 | N/A | -29 | N/A |
1/31/2016 | 2 | -29 | N/A | -24 | N/A |
10/31/2015 | 2 | -25 | N/A | -23 | N/A |
7/31/2015 | 3 | -20 | N/A | -20 | N/A |
4/30/2015 | 3 | -19 | N/A | -21 | N/A |
1/31/2015 | 3 | -17 | N/A | -17 | N/A |
10/31/2014 | 3 | -17 | N/A | -16 | N/A |
7/31/2014 | 4 | -17 | N/A | -16 | N/A |
4/30/2014 | 4 | -13 | N/A | -11 | N/A |
1/31/2014 | 3 | -10 | N/A | -10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if SMMT *'s forecast earnings growth is above the savings rate (8.1%).
Earnings vs Market: Insufficient data to determine if SMMT *'s earnings are forecast to grow faster than the MX market
High Growth Earnings: Insufficient data to determine if SMMT *'s earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SMMT * is forecast to have no revenue next year.
High Growth Revenue: SMMT * is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SMMT * is forecast to be unprofitable in 3 years.